Skip to main content
SpringerLink
Log in

Aliskiren: a rapidly, expanding role in the management of recalcitrant hypertension and renal disease

  • Nephrology - Letter to the editor
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Siamopoulos KC, Kalaitzidis RG (2008) Inhibition of the renin-angiotensin system and chronic kidney disease. Int Urol Nephrol. doi:10.1007/s11255-008-9424-x

    PubMed  Google Scholar 

  2. Parving HH, Persson F, Lewis JB, Lewis EJ, Hollenberg NK, AVOID Study Investigators (2008) Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med 358:2433–2446. doi:10.1056/NEJMoa0708379

    Article  PubMed  CAS  Google Scholar 

  3. Fisher ND, Jan Danser AH, Nussberger J, Dole WP, Hollenberg NK (2008) Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans. Circulation 117:3199–3205. doi:10.1161/CIRCULATIONAHA.108.767202

    Article  PubMed  CAS  Google Scholar 

  4. Cheng JW (2008) Aliskiren: renin inhibitor for hypertension management. Clin Ther 30:31–47. doi:10.1016/j.clinthera.2008.01.011

    Article  PubMed  CAS  Google Scholar 

  5. Andersen K, Weinberger MH, Egan B, Constance CM, Ali MA, Jin J et al (2008) Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial. J Hypertens 26:589–599

    Article  PubMed  CAS  Google Scholar 

  6. Palmer JL, Munk VC, Kotchie RW, Vincze G, Charney A, Tucker DMD et al (2008) 196: cost-effectiveness of aliskiren as add on to losartan and optimal antihypertensive therapy in patients with type 2 diabetes, hypertension and nephropathy in the UK setting. Am J Kidney Dis 51:76. doi:10.1053/j.ajkd.2008.02.206

    Article  Google Scholar 

  7. Kittleson M, Ankrom A, Patel J, Kawano M, Ardehali A, Kobashigawa J (2008) 76: aliskiren—a new anti-renin blood pressure medication appears safe and effective in heart transplant recipients. J Heart Lung Transplant 27:86–87. doi:10.1016/j.healun.2007.11.081

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chicago, IL, 60612, USA

    Shailendra Kapoor

Authors
  1. Shailendra Kapoor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shailendra Kapoor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kapoor, S. Aliskiren: a rapidly, expanding role in the management of recalcitrant hypertension and renal disease. Int Urol Nephrol 40, 1115–1116 (2008). https://doi.org/10.1007/s11255-008-9471-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-008-9471-3

Keywords

Search

Navigation